Complications of myocardial infarction

Article written and reviewed by Dr Luca Moretti

Complications of myocardial infarction are consequences of ischemic necrosis, the inflammatory response, loss of contractile tissue, and the subsequent healing process. They may affect hemodynamics, the ventricular wall, septum, mitral apparatus, electrical system, cardiac chambers, and pericardium. Time after infarction guides suspicion but does not determine it. Any sudden deterioration requires renewed assessment, even when initial revascularization appeared effective.
Early reperfusion has reduced the frequency of cardiac ruptures, which nevertheless remain associated with very high mortality. At the same time, improved survival has made remodeling, heart failure, late arrhythmias, and intracavitary thrombosis more visible; mechanical complications are rare but time-dependent. Functional sequelae are more common and require prolonged prevention.

The manifestations are not interchangeable. A new murmur with pulmonary edema suggests papillary rupture or a septal defect, collapse with a pericardial effusion points toward free-wall rupture, while a cavity outside the ventricular contour requires distinction between a true aneurysm and pseudoaneurysm; the anatomical diagnosis radically changes urgency and treatment. A generic label of post-infarction heart failure is insufficient.
Effective surveillance does not consist of performing every test in every patient. It requires repeated clinical examinations, electrocardiographic monitoring, timely echocardiography when new signs appear, and advanced imaging for selected questions; early recognition precedes support and repair. The clinical cardiologist, intensivist, interventional cardiologist, imaging specialist, and cardiac surgeon must rapidly share data and priorities.

Transitions of care are vulnerable moments: risk does not end with PCI or discharge from intensive care. The echocardiographic report, extent of necrosis, arrhythmias, antithrombotic therapy, and planned follow-up must accompany the patient between wards and after discharge; continuity of care prevents an evolving finding from being lost. The handover should also indicate which symptoms require a new urgent assessment.

Etiology, risk factors, pathogenesis, and pathophysiology

Myocardial necrosis disrupts cellular architecture and reduces the strength of the extracellular matrix. Before the collagen scar matures, infarcted tissue passes through a vulnerable phase in which inflammation, enzymatic digestion, and wall stress may promote discontinuity; myocardial fragility is therefore dynamic. Transmural extent, intracavitary pressure, and local geometry determine which structure may fail.
Extensive infarctions, absent or late reperfusion, and poor collateral circulation increase the amount of nonviable tissue. Advanced age, a first infarction, hypertension, and certain locations have been associated with ruptures in cohorts, but no profile permits their exclusion in an individual patient; delayed presentation remains an important modifiable determinant. Early reopening of the artery limits necrosis and the likelihood of complications.

Free-wall rupture creates a communication between the ventricle and pericardial space; rapid bleeding produces hemopericardium and tamponade, whereas a slowly oozing laceration may have a subacute course. When clots, adhesions, or the pericardium contain the defect, a post-infarction ventricular pseudoaneurysm may form. Contained rupture does not represent stable healing. The cavity wall lacks normal resistant myocardium.
Septal necrosis may open a left-to-right shunt, with acute right ventricular overload and reduced systemic output. Post-infarction ventricular septal rupture may be simple or complex, particularly in inferior infarctions; the acute shunt rapidly increases pulmonary pressure. Defect size, biventricular function, and vascular resistance determine instability.

The posteromedial papillary muscle more often depends on a single arterial supply and is therefore particularly vulnerable to an inferior infarction. Partial or complete papillary muscle rupture causes sudden loss of coaptation and acute mitral regurgitation after myocardial infarction; the atrial volume load encounters an unadapted chamber. Pulmonary pressure and edema may increase within minutes.
When the wall does not rupture, a transmural infarction may expand and progressively alter ventricular shape and volume. Thinning, fiber elongation, global dilation, and neurohormonal activation fuel adverse remodeling; a post-infarction ventricular aneurysm is an expanded scar that retains the layers of the wall. Its dyskinesia diverts effective stroke volume and increases stress on residual myocardium.

Apical akinesia, endocardial injury, and the prothrombotic state of infarction fulfill Virchow's triad and promote left ventricular thrombus after myocardial infarction. Contact between transmural necrosis and the pericardium may instead cause early post-infarction pericarditis, while a delayed immune response sustains Dressler syndrome. Apical stasis and pericardial inflammation are distinct pathways requiring different therapies.
Microvascular obstruction and intramyocardial hemorrhage may enlarge injury despite angiographic reopening of the artery. Edema, obstructed capillaries, and microcirculatory compression limit recovery, promoting remodeling and arrhythmias; reperfusion injury does not negate the benefit of timely revascularization. It does, however, explain why epicardial patency does not always guarantee preserved ventricular function.

Classification, pathological anatomy, and evolution

A clinically useful classification separates electrical, hemodynamic, mechanical, thromboembolic, inflammatory, and remodeling events. Categories may overlap: septal rupture causes shock, an aneurysm sustains tachycardia and thrombus, and papillary rupture causes valvular insufficiency and congestion; a mechanistic classification avoids counting the same process as independent diseases. It primarily serves to establish diagnostic and therapeutic priorities.
Temporally, arrhythmias and pump failure may occur during initial ischemia; cardiac ruptures more often emerge within hours or the first few days; thrombus and early pericarditis may develop during hospitalization; aneurysm, chronic heart failure, monomorphic tachycardia, and Dressler syndrome are typically later. The temporal sequence nevertheless remains variable. Incomplete reperfusion or delayed diagnosis may shift the time of presentation.

Ruptures include the free wall, septum, and papillary muscle. They may be complete, partial, direct or serpiginous, explosive or slowly oozing; morphology influences shunt, bleeding, and repairability; necrotic tissue makes the lesion margin unstable. A single echocardiographic measurement does not always describe the true intramyocardial extent.
A true aneurysm contains endocardium, scarred myocardium, and pericardium, generally has a broad continuity with the cavity, and is often anterior or apical after left anterior descending artery infarction. A pseudoaneurysm is instead a pericardial cavity communicating through a rupture and occurs more often inferiorly or posterolaterally. Wall composition takes precedence over shape. The neck-to-sac ratio alone is not an absolute criterion.

Post-infarction remodeling does not necessarily coincide with a circumscribed aneurysm. It may produce diffuse dilation, spherical remodeling, functional mitral regurgitation, and progression to ischemic cardiomyopathy even without a recognizable sac; ventricular geometry alters mechanical efficiency and prognosis. End-systolic volume, ejection fraction, scar, and right ventricular function should be interpreted together.
A thrombus may be laminated, protruding, sessile, or mobile, and fresh or organized. The probability of embolism cannot be inferred from a single feature, but mobility and protrusion increase clinical concern; thrombus maturation changes during follow-up. An equivocal apical echocardiographic finding should be confirmed with contrast or MRI before imposing prolonged treatment.

Pericardial syndromes are divided into an early form caused by local extension of inflammation and a delayed immune-mediated form. Both may cause effusion, but new pericardial fluid after infarction first requires exclusion of rupture; a post-infarction effusion is not automatically benign. Distribution, rate of accumulation, hemodynamic characteristics, and hemoglobin trends guide urgency.
Complications may also be termed immediate, early, and late only for organizational purposes. A patient with an unrecognized infarction may present directly with a pseudoaneurysm or embolism without a certain date of the causal event; clinical timing should therefore include previous ECGs, biomarkers, scar, and symptom history. Temporal uncertainty should be acknowledged rather than resolved through arbitrary classification.

Signs and symptoms

Hypotension, cold skin, altered mental status, oliguria, and elevated lactate indicate hypoperfusion but do not identify its cause. After infarction, loss of contractility, persistent ischemia, right ventricular infarction, arrhythmia, hemorrhage, and a mechanical complication must be considered; post-infarction shock requires immediate echocardiography. Attributing it solely to ejection fraction may delay lifesaving repair.
A new systolic murmur suggests a septal shunt or mitral regurgitation but may be faint or absent in severe shock because the gradient and output are reduced. A thrill, radiation, prominent v waves, and congestion help without replacing Doppler; a new murmur is a warning sign, not a requirement. An apparently unimpressive physical examination does not exclude complete rupture.

Sudden dyspnea, hypoxemia, crackles, and pulmonary edema are typical of acute mitral regurgitation but also occur with a septal shunt and ventricular failure. Radiography may show asymmetric edema in eccentric regurgitation. Sudden edema should be interpreted with echocardiography. Initially preserved arterial pressure does not guarantee stability over the following hours.
Persistent or recurrent chest pain may reflect ischemia, reinfarction, pericarditis, or a subacute rupture. Pleuritic pain relieved by sitting and a friction rub point toward the pericardium, while syncope, restlessness, and electromechanical dissociation suggest tamponade; post-infarction pain must not be classified by quality alone. ECG, troponin, hemodynamics, and imaging define the new event.

Palpitations, presyncope, or syncope may result from ventricular tachycardia arising from the scar. During the acute phase, ventricular fibrillation and polymorphic tachycardia often reflect ischemia and electrical instability, whereas months later monomorphic tachycardia suggests reentry in the scar border zone; the arrhythmic phenotype changes as the infarction matures. Treatment must distinguish a reversible trigger from a persistent substrate.
Progressive heart failure, reduced exercise tolerance, orthopnea, and peripheral swelling may signal remodeling or a true aneurysm. Neurological events or peripheral ischemia may be the first manifestation of an unrecognized ventricular thrombus; a late presentation may therefore occur far from the heart. A history of a large anterior infarction increases suspicion but does not replace imaging.

Fever, asthenia, pleuritic pain, and increased inflammatory markers weeks after the event point toward Dressler syndrome, but infection, pulmonary embolism, and recurrent ischemia must be excluded. Vascular or infectious complications must also be considered after invasive procedures; post-infarction fever has many causes. An immune-mediated diagnosis requires consistent timing and absence of more urgent explanations.
The daily examination looks for changes from baseline: increased heart rate, reduced pulse pressure, new heart sounds, jugular venous distention, pulsus paradoxus, a thrill, and congestion. Its value derives primarily from observed change, not from the specificity of an individual finding; serial physical findings complement instrumental monitoring. Recording the time of onset helps correlate symptoms, medications, and images.

Investigations and diagnosis

Bedside transthoracic echocardiography is the initial cornerstone because it assesses biventricular function, regional wall motion, effusion, chamber collapse, shunt with color Doppler, and mitral regurgitation. It should be repeated if the presentation changes, even after a previous reassuring examination. Urgent ultrasonography answers immediate questions. Limited quality or an incongruent result requires a complementary method, not a false exclusion.
Transesophageal echocardiography improves visualization of the mitral apparatus, septum, and posterior structures when the transthoracic window is inadequate. In an unstable patient, it should be performed without delaying support or transfer to the operating room; the transesophageal approach is a targeted examination. Sedation, ventilation, and hemodynamic risk require coordination with intensive care and cardiac surgery.

Continuous ECG monitoring identifies arrhythmias and ischemic changes, while troponin, complete blood count, coagulation tests, renal function, blood gas analysis, and lactate quantify injury and systemic consequences. No biomarker confirms cardiac rupture; serial monitoring describes the trajectory. Falling hemoglobin with an enlarging effusion or rising lactate should accelerate imaging and decision-making.
Cardiac magnetic resonance imaging is particularly useful in stable patients for volumes, scar, viability, thrombus, and differentiation between a true aneurysm and pseudoaneurysm. Late enhancement delineates infarcted myocardium, while the absence of myocardial layers in the wall supports contained rupture; tissue characterization completes echocardiography. It is inappropriate when instability and suspected rupture require immediate intervention.

Cardiac CT offers high anatomical resolution and describes the neck, sac, calcification, thrombus, and relationships with coronary arteries and thoracic structures. It is useful for planning surgery or transcatheter closure, particularly if MRI is contraindicated; tomographic reconstruction defines access and margins. Radiation, contrast, and transport must be justified by a question capable of changing management.
Coronary angiography defines the culprit artery and anatomy for possible revascularization; ventriculography and hemodynamic measurements may show a shunt or cavity, but high-pressure injection is unnecessary if a rupture is already documented noninvasively; the invasive strategy must avoid unnecessary delays and risks. The benefit of knowing coronary anatomy is balanced against stability and time to repair.

Principles for recognizing a post-infarction complication

• New clinical or hemodynamic deterioration after a documented infarction.
• Immediate integration of physical examination, ECG, monitoring, and echocardiography.
• Definition of the mechanism: pump failure, arrhythmia, rupture, valvular disease, thrombus, or pericarditis.
• Advanced imaging only if compatible with stability and capable of changing the decision.
• Early discussion with a cardiac surgery center for every suspected mechanical complication.

The differential diagnosis includes reinfarction, stent thrombosis, aortic dissection, pulmonary embolism, hemorrhage, sepsis, a drug reaction, and respiratory causes. Multiple processes may coexist, such as shock from an extensive infarction worsened by mitral regurgitation; an integrated diagnosis does not necessarily seek a single cause. The contribution of each mechanism to current compromise should be quantified.
Right heart catheterization is not required to diagnose every complication but may clarify complex shock when echocardiography and clinical findings disagree. Pressures, output, and saturations permit recognition of a shunt and guide support without replacing anatomical visualization; hemodynamic profiling is selective. Catheter placement must have a purpose and must not delay an already indicated correction.

Treatment and prognosis

The first preventive measure is to reduce ischemic time through recognition of infarction and timely reperfusion. After the acute phase, antithrombotic therapy, intensive lipid lowering, risk factor control, and rehabilitation reduce recurrences and promote recovery; secondary prevention remains necessary even after successful repair. Correcting the complication does not eliminate the causal coronary disease.
During acute deterioration, hypoxemia, arrhythmias, and hypoperfusion are treated while avoiding interventions that worsen the mechanism. Vasodilators may be useful in mitral regurgitation if pressure permits but harmful in shock; excessive fluids may worsen edema and shunting; physiological stabilization is specific to the lesion. Support must not become an indefinite postponement of necessary repair.

Free-wall rupture, septal defect, and papillary rupture require urgent cardiac surgical consultation. Optimal timing depends on shock, anatomy, and tissue friability: waiting for a stronger scar may facilitate some repairs but is impossible in unstable patients; the timing decision balances immediate and operative risks. It must be continuously reassessed by a multidisciplinary team.
Circulatory support devices may create a bridge to repair or recovery in selected patients. The choice among an intra-aortic balloon pump, microaxial pumps, extracorporeal oxygenation, or combined configurations depends on the lesion, compromised ventricle, and center experience; mechanical support is not neutral. Bleeding, limb ischemia, hemolysis, and modification of shunts must be considered before implantation.

A true aneurysm is initially treated with heart failure therapy, ischemic prevention, and management of arrhythmias or thrombus. Ventricular reconstruction is not automatically added to bypass surgery because it did not improve the primary outcome in the randomized STICH population; surgical selection considers refractory symptoms, geometry, viability, arrhythmias, and emboli. A pseudoaneurysm, as a contained rupture, instead requires early evaluation for repair.
Documented ventricular thrombus is anticoagulated according to morphology and embolic and bleeding risks, with follow-up imaging to verify resolution. Pericarditis is treated while preserving post-infarction healing and considering interactions with antithrombotic therapy; causal treatment avoids undifferentiated protocols. An anticoagulant or anti-inflammatory drug should not be prescribed merely because the patient has had an infarction.

Prognosis is extremely heterogeneous. A rupture with shock carries an extremely high immediate risk, whereas a small inflammatory effusion may resolve; a stable aneurysm may be followed for years, but heart failure, tachycardia, and thrombus worsen its course; residual risk depends on ventricular function, scar, and comorbidities. Follow-up and rehabilitation should include clear instructions for new symptoms.
After discharge, ventricular volume and function are reassessed when recovery may change treatment or indications for devices. Blood pressure, heart rate, renal function, and potassium guide drug titration; adherence and tolerability should be directly verified; scheduled reassessment avoids definitive decisions during the transient phase. Timing depends on severity, the procedure performed, and residual findings.

Complications

The final common pathway of major complications is cardiogenic shock caused by loss of contractility, shunting, mitral regurgitation, or tamponade. Mechanisms may combine and produce multiorgan failure, acidosis, and coagulopathy; refractory shock reduces the probability of success of every procedure. Early recognition and transfer are therefore integral parts of treatment.
Free rupture may progress to tamponade and arrest with pulseless electrical activity. A pseudoaneurysm may rupture again, while a septal defect may enlarge in necrotic tissue and partial papillary rupture may progress; anatomical progression justifies close surveillance. Transient improvement does not demonstrate that the lesion has stabilized.

The post-infarction scar creates slow-conduction channels that sustain monomorphic ventricular tachycardia. A reduced ejection fraction increases the risk of sudden death, but risk stratification for a defibrillator must respect guideline timing and criteria; the scar substrate may require medication, ablation, and a device. Intervention on an aneurysm does not automatically replace indicated arrhythmic protection.
Stasis and thrombus may cause stroke or mesenteric, renal, or peripheral ischemia. Emboli may occur before the thrombus is recognized or despite treatment, while anticoagulation increases bleeding risk in a patient often already treated with antiplatelet agents; the thrombotic-bleeding balance must be reassessed. Treatment duration and combinations are not the same for everyone.

Remodeling may progress to chronic heart failure, functional mitral regurgitation, pulmonary hypertension, and right ventricular dysfunction. Recurrent admissions, cachexia, and renal failure indicate an advanced phase that may require ventricular assistance or transplantation in appropriate candidates; ischemic cardiomyopathy is a systemic sequela. Preventing dilation is more effective than treating only its terminal stages.
Pericarditis may recur or produce a significant effusion; inflammatory tamponade is less common but must be distinguished from bleeding. Antithrombotic therapy, renal function, and gastrointestinal risk complicate drug selection; pericardial recurrence requires confirmation of inflammatory activity. Isolated pain without objective signs requires reconsideration of alternative diagnoses.

The procedures themselves may cause bleeding, stroke, renal failure, infection, vascular injury, hemolysis, or lesion recurrence. After surgical or transcatheter repair, imaging and clinical follow-up consistent with the technique and material used are required; procedural iatrogenesis enters the overall prognosis. Communication between the interventional center and community follow-up reduces omissions and duplication.
A less measurable complication is loss of independence after intensive care, surgery, and prolonged hospitalization. Acquired weakness, anxiety, depression, and fear of exertion may limit recovery even when repair is anatomically sound; multidimensional rehabilitation includes exercise, nutrition, and psychological support. Functional goals should be shared with the patient and caregivers.